Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Rare Cannabinoid Company: Buy 2 Get 1 Free On All Cannabinoid Tinctures And Gummies + Free CBD, CBG, CBN, THCV Gummies

Rare Cannabinoid Company announces its best-ever Black Friday Deal. Customers can mix-and-match any three products and receive the least expensive one free. Plus, they will receive a free gummies packet containing all of the brand's new high potency CBD, CBG, CBN and THCV gummies when they spend $50 or more. These deals can be combined so people can experience their full apothecary of THCV, Delta-8-THC, CBDV, CBDA, CBC, CBG, CBN, full spectrum Hawaiian CBD, terpenes, 1:1 blends, and strong cannabinoid gummies at amazing prices.


News provided by

Rare Cannabinoid Company

Nov 24, 2021, 04:35 ET

Share this article

Share toX

Share this article

Share toX

Black Friday Deal: Customers can choose any three products and receive the least expensive free. They will also receive free CBD, CBG, CBN and THCV gummies with a $50 purchase.
Black Friday Deal: Customers can choose any three products and receive the least expensive free. They will also receive free CBD, CBG, CBN and THCV gummies with a $50 purchase.

HONOLULU, Nov. 23, 2021 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company announces its best-ever Black Friday Deal: Buy two get one free on its entire apothecary of cannabinoids: THCV, CBDV, Delta-8-THC, CBDA, CBC, CBG, CBN, full spectrum Hawaiian CBD, terpenes and extra strength cannabinoid gummies. In addition, customers can try all of their new CBD, CBG, CBN, and THCV gummies for free when they spend $50 or more. Shop Black Friday Hemp Deals now.

The Hawaiian company's sister-brand Hawaiian Choice CBD is also offering a similar Black Friday buy 2 get 1 free deal and special offer freebies on their real fruit pineapple-passion CBD jellies. Buy Hawaiian CBD here.

Our new Gummies Variety Packets make the perfect stocking stuffers, and, since deals can be combined, we’re seeing customers stocking up on their favorite cannabinoids and getting lots of free items for gifts.

Post this

Rare Cannabinoid Company sells more cannabinoids than any other brand and was the first to offer single extracts of THCV and CBDV for sale, terpene-only blends and has the strongest THCV gummies. Whether one is looking for help losing weight, improving their mood, or falling asleep at night, they have a tincture or gummy that can help. Plus, their gummies make excellent gifts.

"Our new Gummies Variety Packets make the perfect stocking stuffers, and, since deals can be combined, we're seeing customers stocking up on their favorite cannabinoids and getting lots of free items for gifts," said Jennifer Carlile, Rare Cannabinoid Company Co-Founder and Creative Director.

Here's how Rare Cannabinoid Company's deals work:

Buy 2 Get 1 FREE: Buy any three Rare Cannabinoid Company products – mix and match single extracts, ready blends, terpene-only tinctures, or cannabinoid gummies - and you'll receive the least expensive one free.

Spend $50, Get FREE Gummies: Rare Cannabinoid Company just launched the world's first high potency mix-and-match CBD, CBN, CBG and THCV gummies. For any order of $50 or more, customers will receive a free Variety Packet of Gummies. It contains one 25mg lemon THCV gummy, one 30mg huckleberry CBN gummy, one 30mg green apple CBG gummy, and three 30mg strawberry CBD gummies.

Yes, both Black Friday Deals can be combined: This means that customers can choose any three products - for example, a THCV tincture for energy and appetite control in the morning, a CBG tincture for soreness and discomfort, and a bottle of CBN gummies to help them fall asleep at night. With this combination, the pure CBG tincture is the least expensive item and will be free. Since the customer will have spent more than $50, they will also receive the packet of gummies for free.

Not sure what to buy? Rare Cannabinoid Company recently redesigned its website so that customers can now shop by need and easily find the perfect combination for any of the following needs: Energy and Focus, Sleep, Stress Relief, Discomfort, Mood Enhancers, Appetite Suppression, or Nausea.

The company believes that rare cannabinoids work best when added to full spectrum CBD or a broad spectrum CBD for the entourage effect. Each rare cannabinoid offers unique mental and physical effects which is why they should be combined for different needs. These needs and cannabinoid combinations can differ depending on time of day the person's physiological state.

Each product page offers a list of links to scientific and medical research on each cannabinoid. Here's a brief summary of what each cannabinoid is frequently taken for:

THCV (tetrahydrocannabivarin): Acts like a stimulant, as it increases energy and suppresses hunger, shows promise in reducing the risk of type 2 diabetes, anxiety and panic attacks, and addiction to nicotine.

CBN (cannabinol): May promote rest, relaxation, sleep, and is believed to be more strongly sedative than other cannabinoids, especially when combined with delta-8 THC and relaxing terpenes.

Delta-8 THC (delta-8-tetrahydrocannabinol): Relieves discomfort and nausea. Offers similar effects to delta-9-THC with less risk of anxiety or paranoia.

CBC (cannabichromene): Best non-psychoactive cannabinoid for improving mood as it raises levels of the brain's bliss chemical "anandamide."

CBDA (cannabidiolic acid): Reduces nausea and may in reduce inflammation from daily exercise and activities.

CBD (cannabidiol): Promotes stress resilience, a sense of calm, and may reduce inflammation from daily activities.

CBDV (cannabidivarin): May reduce swelling from daily activities and nausea and is being studied for use in people with autism spectrum disorder, muscular dystrophy, seizures, and other disorders.

CBG (cannabigerol): May offer relief from discomfort and is being studied for use against many ailments.

Relax Terpenes: Blend of myrcene, pinene, carene, limonene, and linalool designed to promote rest, relaxation, and sleep especially when combined with cannabinoids.

Relief Terpenes: Blend of pinene, limonene, linalool, caryophyllene designed to reduce pain, inflammation, and stress especially when combined with cannabinoids.

Rare Cannabinoid Company is an American company based in the 50th state of Hawaii. It was established in the first quarter of 2020 and is a pioneer in the "rare" or "minor" cannabinoid industry, offering purified tinctures and gummies of rare cannabinoid and terpenes as well as blends with full spectrum Hawaiian CBD. Its products are sold in more than 200 locations across the United States and by prescription in Brazil.

Rare Cannabinoid Company is the sister brand of Hawaiian Choice, which was established in the fourth quarter of 2017. Hawaiian Choice is a luxury, lifestyle brand that combines premium broad spectrum Hawaiian CBD with organic and wild crafted Hawaiian fruits, essential oils and honey in an assortment of tinctures, edible jellies, topical gels, and pet products. Its products are also sold in more than 200 locations from New York to Tokyo to the Mariana Islands.

Stores interested in stocking Rare Cannabinoid Company and/or Hawaiian Choice products can request a wholesale account at Wellness Orders.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, (808)762-1313, [email protected]

Twitter, LinkedIn

SOURCE Rare Cannabinoid Company

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.